Skip to main
  1. Stocks
  2. Aveanna Healthcare Holdings
  3. Forecast
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 50%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is positioned for durable growth because its private-duty nursing model serves medically complex children in lower-cost home settings, making it attractive to Medicaid MCOs and less exposed to budget pressure than typical Medicaid-reimbursed peers. Management’s long-term organic revenue targets were raised to 5–6% for PDS and 8–10% for HHH, while preferred payor penetration is advancing, with PDS MCO mix at 64% in 2Q and home health episodic mix at 81%. The California Medi-Cal PDN rate increase effective January 2027, along with updated 2026 adjusted EBITDA of $370.7MM and 2027 adjusted EBITDA of $400.6MM, reinforces visibility into stronger volumes, margin expansion, and free cash flow generation.

Bears say

Aveanna Healthcare Hldgs is facing a negative fundamental setup because labor headwinds are assumed to reduce the base case FY27 adjusted EBITDA estimate by 10%, indicating sustained margin pressure in its labor-intensive home care model. Its dependence on Medicaid and Medicaid MCO reimbursement heightens vulnerability if legislative rate initiatives and the company’s preferred payor strategy stall, limiting revenue improvement and pricing leverage. With the multiple retreating to approximately 8x the downside EBITDA estimate, the data imply weak earnings durability and limited valuation support if operational and reimbursement challenges persist.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 50% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

AVAH Analyst Forecast & Price Prediction

Get the latest AVAH stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in AVAH

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Nov 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


AVAH Analyst Forecast & Price Prediction

Get the latest AVAH stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in AVAH

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover AVAH stock data and trends